Mild Stimulation IVF — Lower Dose, Same Goal

Mild stimulation IVF uses lower doses of FSH (sometimes with letrozole or clomiphene adjuncts) to recruit fewer but high-quality eggs. Lower medication burden, lower cost, less OHSS risk. This page explains when mild stimulation is the right choice.

1. What mild stimulation means

Lower-dose FSH (typically 150 IU or less daily versus 225–450 IU in conventional protocols). Often combined with letrozole or clomiphene to boost endogenous FSH release. Targets 4–8 mature eggs rather than maximising egg yield. Fewer monitoring visits, fewer injections, lower cost per cycle.

2. Who benefits

Poor ovarian responders — high doses fail to recruit additional follicles, so lower doses save medication without losing yield. Patients preferring minimal hormonal load. Repeated full-dose IVF cycles without success — change strategy. Patients with concerns about long-term safety of intensive stimulation. Limited budgets where lower cost per cycle enables more cycles.

3. Egg yield expectations

4–8 mature eggs typical (versus 8–15 in conventional). Per-cycle pregnancy rates lower than conventional in good responders. Cumulative across multiple cycles in poor responders — comparable to conventional, sometimes better. Quality may be preserved or even improved with gentler stimulation in some patient subgroups.

4. Letrozole-assisted protocols

Letrozole (aromatase inhibitor) for 5 days starting day 2–3 of cycle. Reduces estrogen, boosts endogenous FSH production. Lower exogenous FSH doses needed. Particularly useful for poor responders. Sometimes used in oncofertility (cancer patients where estrogen elevation is problematic). Off-label use but well-established.

5. Clomiphene-assisted protocols

Clomiphene citrate 100 mg daily for 5 days. Similar mechanism to letrozole. Used in mini-IVF protocols. Lower cost than gonadotropins. Less commonly used now as letrozole has shown better outcomes with fewer side effects.

6. Monitoring and cycle management

Fewer monitoring visits than conventional (2–3 versus 4–6). Lower estradiol levels make follicle counting more important than blood monitoring. Trigger timing similar to conventional protocols. Retrieval same procedure but fewer eggs collected.

7. Cumulative outcomes

Per cycle: lower pregnancy rates than conventional in good responders. Cumulative across 2–3 cycles: comparable or better than 1 conventional cycle in poor responders. Total cost across multiple mild cycles may be similar or lower than fewer conventional cycles. Less psychological and physical burden per cycle.

8. When mild is not appropriate

Time-critical cases (oncofertility, advanced maternal age with limited cycles) — conventional maximises egg yield per cycle. Young good responders seeking single embryo transfer with PGT (need euploid embryos from cohort) — conventional more efficient. Patients comfortable with intensive stimulation and seeking maximum eggs per cycle. Mild is one tool among several, not universally preferred.

Frequently Asked Questions

Dr. Priyadatt Patel

Senior Gynecologist · Advanced Laparoscopic Surgeon · IVF and Endometriosis Programme Lead

MS OBGyn · Pregnancy Care · Advanced Gynaecological Ultrasound · Fertility Preservation

ESHRE / ESGE / AAGL / ASRM guideline-aligned practice. 3D Karl Storz precision technique. Fertility-preservation-first philosophy. Evidence-based decisions, honest counselling, long-term outcomes orientation.